These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


102 related items for PubMed ID: 7750192

  • 21. The remarkable proliferation of helper T cell subset in response to autologous thyrocytes and intrathyroidal T cells from patients with Graves' disease.
    Eguchi K, Otsubo T, Kawabe Y, Ueki Y, Fukuda T, Matsunaga M, Shimomura C, Ishikawa N, Tezuka H, Nakao H.
    Clin Exp Immunol; 1987 Nov; 70(2):403-10. PubMed ID: 2962792
    [Abstract] [Full Text] [Related]

  • 22. Effects of interferon-gamma and tumour necrosis factor-alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanoma.
    Roth AD, Hornicek FJ, Gerstner CG, Kirkwood JM.
    Clin Exp Immunol; 1991 Oct; 86(1):163-72. PubMed ID: 1833098
    [Abstract] [Full Text] [Related]

  • 23. Effect of FK-506 on xenografted human Graves' thyroid tissue is severe combined immunodeficient mice.
    Yoshikawa N, Arreaza G, Mukuta T, Resetkova E, Miller N, Jamieson C, Nishikawa M, Inada M, Volpé R.
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):31-9. PubMed ID: 7519528
    [Abstract] [Full Text] [Related]

  • 24. Expression of adhesion molecules on infiltrating T cells in thyroid glands from patients with Graves' disease.
    Ishikawa N, Eguchi K, Ueki Y, Nakashima M, Shimada H, Ito K, Nagataki S.
    Clin Exp Immunol; 1993 Nov; 94(2):363-70. PubMed ID: 7900942
    [Abstract] [Full Text] [Related]

  • 25. Modulation of Fas-mediated apoptosis of human thyroid epithelial cells by IgG from patients with Graves' disease (GD) and idiopathic myxoedema.
    Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Urayama S, Kawabe Y, Tahara K, Ishikawa N, Ito K, Nagataki S.
    Clin Exp Immunol; 1997 Dec; 110(3):434-9. PubMed ID: 9409648
    [Abstract] [Full Text] [Related]

  • 26. Analysis of cytokine gene expression in Graves' disease and multinodular goiter.
    Watson PF, Pickerill AP, Davies R, Weetman AP.
    J Clin Endocrinol Metab; 1994 Aug; 79(2):355-60. PubMed ID: 8045947
    [Abstract] [Full Text] [Related]

  • 27. Intercellular adhesion molecule-1 (ICAM-1) in Graves' disease: contrast between in vivo and in vitro results.
    Ciampolillo A, Napolitano G, Mirakian R, Miyasaki A, Giorgino R, Bottazzo GF.
    Clin Exp Immunol; 1993 Dec; 94(3):478-85. PubMed ID: 7902787
    [Abstract] [Full Text] [Related]

  • 28. Lack of intrathyroidal tumor necrosis factor alpha in Graves' disease.
    Paschke R, Kist A, Jänicke R, Eck T, Velu T, Usadel KH.
    J Clin Endocrinol Metab; 1993 Jan; 76(1):97-102. PubMed ID: 8421109
    [Abstract] [Full Text] [Related]

  • 29. IFN-gamma has a protective role against thyroid-specific autoantibody production in severe combined immunodeficient (SCID) mice xenografted with Graves' thyroid tissue.
    Yoshikawa N, Mori S, Tokoro T, Ikehara S, Kumazawa H, Yamashita T, Nishikawa M, Inada M.
    Thyroid; 1996 Oct; 6(5):437-43. PubMed ID: 8936668
    [Abstract] [Full Text] [Related]

  • 30. Increased production of B-cell growth factor by T lymphocytes in Graves' thyroid: possible role of CD4+ CD29+ cells.
    Goto Y, Itoh M, Ohta Y, Ogawa N, Goto Y, Ohashi H.
    Thyroid; 1997 Aug; 7(4):567-73. PubMed ID: 9292944
    [Abstract] [Full Text] [Related]

  • 31. The effects of royal jelly on autoimmunity in Graves' disease.
    Erem C, Deger O, Ovali E, Barlak Y.
    Endocrine; 2006 Oct; 30(2):175-83. PubMed ID: 17322576
    [Abstract] [Full Text] [Related]

  • 32. Intrathyroidal T cell clones from patients with autoimmune thyroid disease.
    MacKenzie WA, Schwartz AE, Friedman EW, Davies TF.
    J Clin Endocrinol Metab; 1987 Apr; 64(4):818-24. PubMed ID: 2880865
    [Abstract] [Full Text] [Related]

  • 33. Thyrocyte targets and effectors of autoimmunity: a role for death receptors?
    Hammond LJ, Palazzo FF, Shattock M, Goode AW, Mirakian R.
    Thyroid; 2001 Oct; 11(10):919-27. PubMed ID: 11716038
    [Abstract] [Full Text] [Related]

  • 34. Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands.
    Marazuela M, Postigo AA, Acevedo A, Díaz-González F, Sanchez-Madrid F, de Landázuri MO.
    Eur J Immunol; 1994 Oct; 24(10):2483-90. PubMed ID: 7523142
    [Abstract] [Full Text] [Related]

  • 35. Microsomal antigen-reactive lymphocyte lines and clones derived from thyroid tissue of patients with Graves' disease.
    Fisfalen ME, DeGroot LJ, Quintans J, Franklin WA, Soltani K.
    J Clin Endocrinol Metab; 1988 Apr; 66(4):776-84. PubMed ID: 3257970
    [Abstract] [Full Text] [Related]

  • 36. Phenotypic analyses and concanavalin-A-induced suppressor cell dysfunction of intrathyroidal lymphocytes from patients with Graves' disease.
    Ueki Y, Eguchi K, Otsubo T, Kawabe Y, Shimomura C, Matsunaga M, Tezuka H, Nakao H, Kawakami A, Izumi M.
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1018-24. PubMed ID: 2972737
    [Abstract] [Full Text] [Related]

  • 37. Involvement of inducible costimulator ligand (ICOSL) expression in thyroid tissue in hyperthyroidism of Graves' disease patients.
    Wang F, Yan T, Chen L, Chen X, Liu T, Shen S, Li T, Gao L, Wang T, Sun J, Liu C, Wu H, Zhang X, Chen L.
    J Clin Immunol; 2012 Dec; 32(6):1253-61. PubMed ID: 22706735
    [Abstract] [Full Text] [Related]

  • 38. Nontoxic nodular goiter and papillary thyroid carcinoma are not associated with peripheral blood lymphocyte sensitization to thyroid cells.
    Aguayo J, Sakatsume Y, Jamieson C, Row VV, Volpé R.
    J Clin Endocrinol Metab; 1989 Jan; 68(1):145-9. PubMed ID: 2462573
    [Abstract] [Full Text] [Related]

  • 39. Studies of HLA-DR expression on cultured human thyrocytes: effect of antithyroid drugs and other agents on interferon-gamma-induced HLA-DR expression.
    Aguayo J, Iitaka M, Row VV, Volpé R.
    J Clin Endocrinol Metab; 1988 May; 66(5):903-8. PubMed ID: 3129449
    [Abstract] [Full Text] [Related]

  • 40. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.
    Matsubayashi S, Akasu F, Kasuga Y, Snow K, Keystone E, Volpé R.
    Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.